Drug Profile
Research programme: muscarinic M1 receptor agonists - Eli Lilly and Company
Alternative Names: LY 593093Latest Information Update: 22 Apr 2009
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Class Small molecules
- Mechanism of Action Muscarinic M1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cognition disorders
Most Recent Events
- 22 Apr 2009 No development reported - Preclinical for Cognition disorders in USA (unspecified route)
- 07 Apr 2003 Preclinical trials in Cognition disorders in USA (unspecified route)